Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Evaluation of the Wheelchair School (Drivkraft) a Clinical Study

NCT07131553 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2025-10-01
Last updated
2025-08-20

Condition(s) studied

Neurological DisordersWheelchair MobilityRehabilitation

Investigational drug(s) / intervention(s)

Wheelchair schoolComparison group, conventional rehabilitation

Wheelchair school: Wheelchair skills training with pysiotherapist and peer mentor

Comparison group, conventional rehabilitation: Conventional rehabilitation at the same unit of similiar length and intensity

Study summary

This project will evaluate the Wheelchair School with the Drivkraft Methodology in a clinical setting. Participants are adults with chronic neurological diagnoses. For a person requiring a wheelchair, a well-functioning, individually adapted wheelchair and good maneuvering skills are essential for an independent daily life. These factors are also crucial in reducing the risk of secondary complications and pain. The Wheelchair School was founded in the 1990s, is provided by referral and both peer mentors and physiotherapists collaborate. It includes wheelchair prescription and adjustments, individually adapted wheelchair skills training, and theoretical lessons in group during 16 half-day sessions.

The overarching aim is to evaluate the intervention Wheelchair school with the Drivkraft method, for wheelchair skills and patient safety for persons with chronic neurological diagnoses in a Swedish context. Also to evaluate the psychometric properties of the Drivkraft Manouevering Test (DWMT) for wheelchair skills.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Participant in the Drivkraft Wheelchair school at Aleris Rehab Station * Adult with neurological diagnosis using manual wheelchair Exclusion Criteria: * Persons with Parkinsons Disease * Persons with too limited Swedish language skills to fill in study forms or make a signed consent * Persons with cognitive impairments affecting their ability to fill in study forms or make a signed consent

Primary outcome measure(s)

  • Drivkraft manouevering test — baseline, post intervention and at 2 months follow-up
    Test of wheelchair skills: curbs, slalom, ramps and wheelies

Trial sites (1)

FacilityCityRegionStatus
Aleris Rehab Station Solna Sweden
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07131553 on ClinicalTrials.gov ↗ ← All trials in Sweden